Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilia B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03407651
What this trial is testing

Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Catalyst Biosciences 11
Early research (Phase 1)Study completedNCT00716716
What this trial is testing

Phase I/IIa Study of FIXFc in Hemophilia B Patients

Who this might be right for
Hemophilia B
Bioverativ Therapeutics Inc. 10
Testing effectiveness (Phase 2)Study completedNCT05619926
What this trial is testing

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 32
Testing effectiveness (Phase 2)Study completedNCT03489291
What this trial is testing

Dose Confirmation Trial of AAV5-hFIXco-Padua

Who this might be right for
Hemophilia B
CSL Behring 3
Not applicableStudy completedNCT00515710
What this trial is testing

LTFU for Gene Transfer Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Spark Therapeutics, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT01361126
What this trial is testing

A Safety and Efficacy Study of a Recombinant Factor IX in Patients With Severe Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 17
Post-approval studies (Phase 4)Study completedNCT03565237
What this trial is testing

RIXUBIS PMS India (RIXUBIS PMS)

Who this might be right for
Hemophilia B
Baxalta now part of Shire 25
Not applicableLooking for participantsNCT05630651
What this trial is testing

The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.

Who this might be right for
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China 6
Early research (Phase 1)Study completedNCT02035605
What this trial is testing

An Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients

Who this might be right for
Hemophilia AHemophilia B
Sanofi 51
Not applicableStudy completedNCT03596814
What this trial is testing

MOTHIF II : THERAPEUTIC MANAGEMENT AND USE OF CLOTTING FACTORS IN HEMOPHILIA A & B IN FRANCE II

Who this might be right for
Hemophilia
Nantes University Hospital 2,072
Early research (Phase 1)Study completedNCT01379300
What this trial is testing

Investigate Biomarkers After Single Doses of Anticoagulants in Healthy Young Male and Healthy Elderly Participants (MK-0000-216 AM1)

Who this might be right for
Thrombosis
Merck Sharp & Dohme LLC 42
Not applicableStudy completedNCT05617209
What this trial is testing

In Vitro Correction of Thrombin Generation by Concizumab (Anti-TFPI) for Severe Hemophilia Patients

Who this might be right for
Hemophilia
Centre Hospitalier Universitaire de Saint Etienne 20
Large-scale testing (Phase 3)Ended earlyNCT02895945
What this trial is testing

BAX 802 in CHA With Inhibitors

Who this might be right for
Hemophilia A
Baxalta now part of Shire 8
Large-scale testing (Phase 3)Study completedNCT01662531
What this trial is testing

A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 27
Testing effectiveness (Phase 2)Looking for participantsNCT05641610
What this trial is testing

Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients

Who this might be right for
Hemophilia B
Institute of Hematology & Blood Diseases Hospital, China 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07724834
What this trial is testing

CD19-B Cell Depletion in PAIS-ME/CFS Patients

Who this might be right for
Post-acute Infectious Syndrome (PAIS)Post-COVID 19 Condition (PCC or Long COVID)Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Charite University, Berlin, Germany 38
Testing effectiveness (Phase 2)Study completedNCT05027230
What this trial is testing

A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 77
Not applicableStudy completedNCT04055051
What this trial is testing

ATHN 11: Liver Transplantation Outcomes Study

Who this might be right for
Hemophilia A and BLiver Transplantation
American Thrombosis and Hemostasis Network 86
Post-approval studies (Phase 4)Study completedNCT01128881
What this trial is testing

IMMUNINE Pre-Treatment Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 57
Post-approval studies (Phase 4)Study completedNCT00749476
What this trial is testing

Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IX

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 1
Next Page